Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol

Author:

Vahid FarhadORCID,Dessenne CoralieORCID,Tur Josep AORCID,Bouzas CristinaORCID,Devaux YvanORCID,Malisoux LaurentORCID,Monserrat-Mesquida MargalidaORCID,Sureda AntoniORCID,Desai Mahesh SORCID,Turner Jonathan DORCID,Lamy ElsaORCID,Perez-Jimenez MariaORCID,Ravn-Haren GitteORCID,Andersen RikkeORCID,Forberger SarahORCID,Nagrani RajiniORCID,Ouzzahra Yacine,Fontefrancesco Michele FilippoORCID,Onorati Maria GiovannaORCID,Bonetti Gino Gabriel,de-Magistris TizianaORCID,Bohn TorstenORCID

Abstract

IntroductionDespite international efforts, the number of individuals struggling with obesity is still increasing. An important aspect of obesity prevention relates to identifying individuals at risk at early stage, allowing for timely risk stratification and initiation of countermeasures. However, obesity is complex and multifactorial by nature, and one isolated (bio)marker is unlikely to enable an optimal risk stratification and prognosis for the individual; rather, a combined set is required. Such a multicomponent interpretation would integrate biomarkers from various domains, such as classical markers (eg, anthropometrics, blood lipids), multiomics (eg, genetics, proteomics, metabolomics), lifestyle and behavioural attributes (eg, diet, physical activity, sleep patterns), psychological traits (mental health status such as depression) and additional host factors (eg, gut microbiota diversity), also by means of advanced interpretation tools such as machine learning. In this paper, we will present a protocol that will be employed for a scoping review that attempts to summarise and map the state-of-the-art in the area of multicomponent (bio)markers related to obesity, focusing on the usability and effectiveness of such biomarkers.Methods and analysisPubMed, Scopus, CINAHL and Embase databases will be searched using predefined key terms to identify peer-reviewed articles published in English until January 2024. Once downloaded into EndNote for deduplication, CADIMA will be employed to review and select abstracts and full-text articles in a two-step procedure, by two independent reviewers. Data extraction will then be carried out by several independent reviewers. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews and Peer Review of Electronic Search Strategies guidelines will be followed. Combinations employing at least two biomarkers from different domains will be mapped and discussed.Ethics and disseminationEthical approval is not required; data will rely on published articles. Findings will be published open access in an international peer-reviewed journal. This review will allow guiding future directions for research and public health strategies on obesity prevention, paving the way towards multicomponent interventions.

Funder

Ministry of Higher Education and Research, Luxembourg

COVIRNA

EU COST ACTIONS

Fonds National de la Recherche Luxembourg

HORIZON EUROPE Research and Innovation

Heart Foundation Daniel Wagner Luxembourg

Instituto de Salud Carlos III, Spain, CIBEROBN

COST Association

Horizon Europe Research and Innovation Programme

Publisher

BMJ

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3